Biotech

All Articles

Boundless Bio helps make 'modest' layoffs five months after $100M IPO

.Just 5 months after getting a $100 million IPO, Limitless Bio is actually currently laying off some...

Halda's $126M will certainly progress 'secure and get rid of' growth medications

.The first phases of oncology R&ampD aren't except intriguing brand-new modalities, as well as Halda...

Lykos 'disappointments' certainly not disclosing research infractions with publisher

.Psychopharmacology has actually pulled three write-ups regarding midstage medical test information ...

Analysts dig into Avidity's DMD gain, revealing distinctions in information

.Avidity Biosciences amazed clients along with period 1/2 data in Duchenne muscle dystrophy (DMD) Fr...

Actinogen's cortisol blocker falls short stage 2 depression study

.Actinogen Medical's cortisol blocker has actually skipped the key endpoint of a period 2 research s...

Bivictrix determines going exclusive only technique to take ADC into facility

.Antibody-drug conjugates (ADCs) have gone to the facility of lots of a billion-dollar biobuck licen...

TPG tops up funds to $580M for financial investments throughout lifestyle sciences

.Asset manager TPG, which has supported biotechs such as Sionna Therapeutics and also Santa Clam Ana...

Merck quits phase 3 TIGIT trial in lung cancer for impossibility

.Merck &amp Co.'s TIGIT program has actually gone through an additional setback. Months after shutte...

After a difficult year, Exscientia folds up into Recursion

.After a year determined by pipeline cuts, the departure of its own chief executive officer and disc...

Cullinan, after $25M bargain, return bispecific to Port

.Cullinan Therapeutics was actually impressed sufficient with Port BioMed's bispecific immune reacto...